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Brief report
Selective inactivation of p27Kip1 in hematopoietic progenitor cells increases
neointimal macrophage proliferation and accelerates atherosclerosis
Antonio Dı´ez-Juan, Paloma Pe´rez, Miguel Aracil, David Sancho, Antonio Bernad, Francisco Sa´nchez-Madrid, and Vicente Andre´s
Excessive proliferation of immune cells
and vascular smooth myocytes (VSMCs)
contributes to atherosclerosis. We have
previously shown that whole-body inacti-
vation of the growth suppressor p27 exac-
erbates atherosclerosis in apolipoprotein
E-null mice (apoE/), and this correlated
with increased proliferation of arterial
macrophages and VSMCs. In the present
study, we postulated that targeted disrup-
tion of bone marrow (BM) p27 is sufficient
to enhance arterial macrophage prolifera-
tion and atherosclerosis. To test this hy-
pothesis,sublethally irradiatedapoE/mice
with an intact p27 gene received a BM trans-
plant from either apoE/ or p27/apoE/
doubly deficient donor mice and challenged
with a high-cholesterol diet. Compared with
mice that received an apoE/ BM trans-
plant, reconstitution with p27/apoE/
doubly deficient marrow increased the ex-
pression of proliferating cell nuclear antigen
in neointimal macrophages and accelerated
aortic atherosclerosis, and this correlated
with augmented aortic expression of the
inflammatory cytokines CCL2/MCP-1
(monocyte chemoattractant protein 1) and
CCL5/RANTES (regulated on activation,
normal T-cell expressed and secreted).
Overall, these findings provide evidence
that p27 deficiency in hematopoietic pro-
genitor cells enhances the inflammatory/
proliferative response induced by dietary
cholesterol and accelerates atherosclero-
sis. (Blood. 2004;103:158-161)
© 2004 by The American Society of Hematology
Introduction
Atherosclerotic plaque development is due in part to the recruitment of
circulating blood leukocytes into the artery wall, the migration of
vascular smooth myocytes (VSMCs) from the media toward the
growing neointimal lesion, and hyperplastic cell growth.1,2 The growth
suppressor p27 coordinately inhibits cell proliferation and migration.3
Notably, p27 expression inversely correlates with macrophage and
VSMC proliferation within human atherosclerotic tissue,4 and transform-
ing growth factor  (TGF-) present in human atherosclerotic tissue
may mediate its growth-suppressive activity through p27.5 Furthermore,
doubly deficient p27/apoE/ mice display accelerated atherogenesis
as compared with apoE/ mice with an intact p27 gene.6 This effect of
p27 inactivation was dose dependent and correlated with augmented
proliferation of arterial macrophages and VSMCs. In the present study,
we used a bone marrow (BM) transplantation model to examine
whether targeted inactivation of p27 in hematopoietic precursors is




Female apoE/ mice (C57BL/6J; Taconic M&B, Ry, Denmark) irradiated
with 2 doses of 5.1 Gy spaced 4 hours apart received transplants of 2  106
BM cells obtained from the pooled femur of 2 male apoE/ or doubly
deficient p27/apoE/ mice (C57BL/6J).6 After 4 weeks on a standard
diet (2.8% fat; Panlab, Barcelona, Spain), the mice that received transplants
were fed an atherogenic diet for 2 months (15.8% fat, 1.25% cholesterol,
0.5% sodium cholate, S4892-S010; Ssniff, Soest, Germany). Plasma
cholesterol level was determined as described.6
Quantification of transplantation efficiency, atherosclerosis,
and cytokine expression
Fat-fed mice were killed and genomic DNA was isolated from BM,
spleen, and thymus to quantify transplantation efficiency by polymerase
chain reaction (PCR) amplification of a 184–base pair (bp) fragment of
the Y chromosome–specific Zfy-1 gene. DNA amount was normalized by
quantitative amplification of a 190-bp fragment of the ras gene.
Genomic DNA (20 ng) was amplified in a LightCycler (Roche,
Mannheim, Germany) using the SYBR Green I reaction mix (Roche).
Serially diluted standard samples of male and female DNA were
simultaneously amplified using the same reaction mixture. To quantify
cytokine mRNA expression by real-time PCR, 2 g DNaseI-treated total
RNA obtained from snap-frozen aortic arch tissue (Ultraspec RNA
isolation system; Biotecx, Houston, TX) was reverse transcribed with
MuLV reverse transcriptase (RT) (Roche). Primer sequences and
amplification programs are available upon request. Detection of fluores-
cent product was carried out at the last step of each cycle.
Aortic atherosclerosis was quantified as previously described.6
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Immunohistochemistry and Western blot
Aortic arch cross-sections were immunostained with antibodies against
Mac-3 (1/100, sc-19991; Santa Cruz Biotechnology, Santa Cruz, CA),
smooth muscle -actin (SM-actin) (using an alkaline phosphatase–
conjugated antibody 1/100, clone 1A4; Sigma, St Louis, MO), and
proliferating cell nuclear antigen (PCNA; 1/50, sc-7907; Santa Cruz
Biotechnology). Immunocomplexes containing anti–Mac-3 and anti–
PCNA antibodies were detected using the Ultra Streptavidin detection
system (Level 2; Signet Laboratories, Cambridge, MA) and 3,3-
diaminobenzidine tetrahydrochloride dihydrate substrate (DAB; Sigma).
SM-actin expression was detected using Fast Red substrate (Sigma).
Whole-cell extracts were prepared from cultured NIH3T3 fibroblasts
(American Type Culture Collection, Manassas, VA), BM-derived macro-
phages,7 and from the pooled aortic arch tissue from 4 mice that received
transplants. Lysis buffer (50 mM Tris(tris(hydroxymethyl)aminomethane)–
HCl [pH 7.5], 1% Nonidet P-40 (NP-40), 0.25% sodium deoxycholate, 150
Figure 1. Reconstitution of apoE/ mice with BM
lacking p27 accelerates diet-induced atherosclero-
sis. One month after transplantation, mice were chal-
lenged with a high-cholesterol diet for 2 months. Animals
were then killed and aortic tissue was retrieved to quantify
atherosclerosis (A, B) and for immunohistochemical anal-
ysis (C-E). Results in A and B are given as mean  SE,
and differences between groups were evaluated using
2-tailed, unpaired Student t test. (A) The aorta was removed
from the heart to the renal artery and was stained with Oil
Red O. The area of atheroma (red staining) was quanti-
fied by computerized planimetry. Results are represented
relative to total aortic area. The photomicrographs show
representative examples. (B) Cross-sections of the aortic
arch region were analyzed to measure the area of
atheroma (intimal lesion) and media to determine the
intima-to-media ratio. The red horizontal bars show the
average value in each group. The representative photomi-
crographs in B show specimens doubly immunostained
with antibodies against the macrophage-specific Mac-3
protein (brown signal) and the smooth muscle–specific
 isoform of actin (SM-actin; red signal). The discontinu-
ous lines mark the boundary between the tunica media and
the atheroma. The bars represent 0.2 mm. (C-E) Immuno-
histochemistry of aortic arch cross-sections. Each pair of
photomicrographs correspond to immediately adja-
cent cross-sections of the same mouse (bars represent
100 m). Mac-3 and PCNA are shown in brown, and
SM-actin in red. Analysis included double immuno-
histochemistry using the indicated pairs of antibodies
(C, D) and single immunostaining using anti–Mac-3 and
anti-PCNA antibodies (E). For double immunhistochem-
istry, specimens were first stained for either PCNA
or Mac-3, and then with the alkaline phosphatase–
conjugated anti–SM-actin antibody. In both groups
of mice, abundant immunoreactivity for Mac-3 and
SM-actin is detected within the atheroma and the media,
respectively, and PCNA expression predominates in mac-
rophage-rich regions of atheromas.
Table 1. Physiologic measurements in apoE/3 apoE/ and p27/ apoE/3 apoE/ mice
Bone marrow donor
genotype Weight (g)
Plasma cholesterol (mg/dL) Transplant donor engraftment (%)
Before diet After diet Bone marrow Spleen Thymus
apoE/3 apoE/ 19.6  0.6 (n  15) 336  35 (n  15) 2733  266 (n  15) 43  4 (n  5) 49  5 (n  5) 48  3 (n  5)
p27/ apoE/3 apoE/ 20.4  0.8 (n  15) 363  21 (n  15) 2626  109 (n  15) 44  9 (n  4) 87  5 (n  4)* 67  6 (n  4)
With the exception of prediet plasma cholesterol, all parameters were measured after mice had been killed. Results were compared by 2-tailed, unpaired, Student t test.
Only statistically significant differences are shown (P 	 .05). Results are shown as mean SE.
*P 	 .002.
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mM NaCl, 150 mM EDTA [ethylenediaminetetraacetic acid], 1 mM PMSF
[phenylmethylsulfonyl fluoride], 1 mM orthovanadate, 1 mM NaF, 0.1%
sodium dodecyl sulfate [SDS]) was supplemented with protease inhibitor
Complete Mini cocktail (Roche). Western blot analysis was carried out with
antitubulin (1/200, sc-3035) and anti–Mac-3 (1/200, sc-19991) antibodies
(Santa Cruz Biotechnologies) as previously described.6
Results and discussion
Because reconstitution of apoE/ mice with wild-type BM
markedly reduces atherogenesis,8 we performed our studies with
apoE-null marrow. Female apoE/ mice were sublethally
irradiated and reconstituted with BM from male apoE/ and
p27/apoE/ doubly deficient donors (apoE/3 apoE/ and
p27/apoE/ 3 apoE/ mice, respectively). Animals were
challenged for 8 weeks with a high-fat, cholesterol-rich diet
beginning 1 month after transplantation. apoE/ 3 apoE/ and
p27/apoE/3 apoE/ mice had comparable body weight and
developed similar hypercholesterolemia (Table 1). Likewise, no
statistically significant differences were observed in transplant
efficiency in BM and thymus when comparing both groups.
However, repopulation efficiency in the spleen was significantly
higher in p27/apoE/ 3 apoE/ mice, consistent with previ-
ous transplantation studies with p27-null BM.9
Aortic tissue was examined to quantify the extent of atheroscle-
rosis by 2 independent approaches. First, we examined en face
preparations of the aorta stained with Oil Red O (Sigma) to mark
lipid-laden lesions. Computerized planimetric analysis revealed a
1.85-fold increase in mean lesion area in p27/apoE/ 3
apoE/ versus apoE/ 3 apoE/ mice (P 	 .00005; Figure
1A). Second, quantification of the area of atheroma (intima) and
media in aortic arch cross-sections in another set of mice disclosed
a 2.1-fold increase in the intima-to-media ratio in p27/apoE/
3 apoE/ compared with apoE/ 3 apoE/ counterparts
(P 	 .05; Figure 1B). Thus, reconstitution of apoE-null mice with
p27-deficient BM enhances diet-induced atherosclerosis.
The cellular composition of atherosclerotic lesions was exam-
ined in aortic arch cross-sections by immunohistochemistry with
anti–Mac-3 and anti–SM-actin antibodies to visualize macro-
phages and VSMCs, respectively, which disclosed an overtly
similar histopathology of the atheromas in both groups of mice.
SM-actin was predominantly expressed in the media (Figure
1C-D). In contrast, macrophages prevailed in the atheroma in both
groups (Figure 1C-E). We estimated the relative abundance of
macrophages in aortic tissue by Western blot analysis using the
anti–Mac-3 rat monoclonal antibody. To verify the specificity of
this antibody, we first examined cultures of fibroblasts and
macrophages obtained from wild-type and p27-null mice, which
revealed 2 macrophage-specific bands of similar intensity in
wild-type and p27-null cells (Figure 2A, left). As shown in Figure
2A (right), Mac-3 expression was increased in the aorta of fat-fed
p27/apoE/ 3 apoE/ mice versus apoE/ 3 apoE/
counterparts. Averaged over 3 independent experiments, densitomet-
ric analysis normalized by the internal tubulin loading control
revealed a 2-fold increase in aortic Mac-3 expression in
p27/apoE/ 3 apoE/ versus apoE/ 3 apoE/ mice.
Because the main cellular components of the atherosclerotic
lesions in our studies are macrophages (Figure 1C-E), increased
Mac-3 expression in the aorta of fat-fed p27/apoE/ 3
apoE/ mice is consistent with larger plaques in these animals.
To examine whether p27 inactivation in the transplanted
marrow increases arterial cell growth in recipient mice, we
examined in aortic tissue the expression of the proliferation marker
proliferating cell nuclear antigen (PCNA).10-12 To ascertain the
identity of PCNA-immunoreactive cells, consecutive sections were
examined by either double SM-actin/Mac-3 and SM-actin/
PCNA immunohistochemistry (Figure 1C-D), or by single immuno-
staining with anti-PCNA and anti–Mac-3 antibodies (Figure 1E).
SM-actin/PCNA colocalization was scant, even in intimal SM-
actin–immunoreactive cells (Figure 1C, bottom photomicrograph).
In contrast, Mac-3/PCNA coexpression was abundant in the
atheromas of both apoE/ 3 apoE/ and p27/apoE/ 3
apoE/ mice (Figure 1C-E). PCNA immunoreactivity was higher
in the atheroma versus the media in both groups, and a tendency
toward more PCNA-expressing cells was noted in the atheromas of
p27/apoE/ 3 apoE/ compared with apoE/ 3 apoE/
mice (Figure 2B). Moreover, the proliferative capacity of cultured
p27-null macrophages was significantly higher than that of wild-
type counterparts (data not shown). Overall, these findings are in
agreement with previous studies showing that p27 inactivation
enhances hematopoietic progenitor cell proliferation9 and implicat-
ing p27 as a critical macrophage growth suppressor.13,14 Because
Figure 2. Expression studies in aortic tissue of fat-fed mice that received transplants. (A) Immunoblot analysis using the Mac-3 antibody and lysates of cultured cells
(NIH 3T3 fibroblasts and macrophages—M
—obtained from the BM of wild-type and p27/ mice) and aortic tissue prepared from the pooled descending aortic arch of 3
fat-fed mice. The arrowheads point to macrophage-specific bands. (B) PCNA-immunostained specimens (Figure 1) were analyzed to quantify PCNA-immunoreactive cells per
cross-section, both in the media and atheroma. PCNA-positive cells were counted in at least 3 sections from different regions of the aortic arch and all independent values were
averaged. The dotted horizontal bars indicate the average value in each group. (C) Real-time quantitative RT-PCR analysis of total RNA isolated from the descending aortic
arch to quantify cytokine expression within the atherosclerotic vessel wall. The number of animals in each group is indicated (n). Results are given as mean  SE (ratio of
cytokine/GAPDH [glyceraldehyde-3-phosphate dehydrogenase] mRNA). For each cytokine, average values in both groups were compared using the nonparametric
Mann-Whitney U test (*, P 	 .01; **, P 	 .001). Error bars indicate SE.
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macrophages were the most abundant cells in our study, we suggest
that macrophage p27 safeguards against the inflammatory/
proliferative response induced by dietary cholesterol in apoE-null
mice. These results are consistent with our studies demonstrating
that whole-body inactivation of p27 enhances atherosclerosis.6
Similarly, both systemic15 and macrophage-specific16,17 p53 defi-
ciency enhances diet-induced atherosclerosis. Thus, macrophage
expression of growth suppressors seems to play a crucial role in
atherosclerosis.
We next examined cytokine expression in aortic tissue by
quantitative RT-PCR (Figure 2C). CCL2/MCP-1 (monocyte che-
moattractant protein 1) and CCL5/RANTES (regulated on activa-
tion, normal T cell expressed and secreted) mRNA were signifi-
cantly increased in p27/apoE/3 apoE/ versus apoE/3
apoE/ mice. In contrast, differences in interleukin-4 (IL-4) and
interferon  (IFN-) mRNA expression did not reach statistical
significance. Because CCL2/MCP-1 and CCL5/RANTES promote
macrophage infiltration and atheroma formation,18-20 increased
macrophage infiltration in response to augmented aortic CCL2/
MCP-1 and CCL5/RANTES expression in p27/apoE/ 3
apoE/ mice might contribute to accelerated atherosclerosis in these
animals. It should be noted that lymphocyte recruitment and prolifera-
tion are also implicated in atherogenesis,1,2 and that p27 is a key
regulator of lymphocyte proliferation in different physiopathologic
conditions.21-27 Thus, enhanced lymphocyte activation may also contrib-
ute to the phenotype of p27/apoE/3 apoE/ mice.
In summary, we have shown that targeted p27 inactivation in
hematopoietic progenitors enhances arterial macrophage prolifera-
tion and inflammatory response resulting in accelerated atheroscle-
rosis. It is noteworthy that retrovirus-mediated constitutive p27
overexpression impaired the engraftment of transplanted cells in
our murine model (V. A., A. D.-J., M. A., and A. B, unpublished
results, October 2002). Thus, future studies using an inducible,
macrophage-specific promoter are warranted to examine whether
increasing p27 expression in macrophages may reduce atheroma
development.
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